Trial watch: Tracing investment in drug development for Alzheimer disease
Nat Rev Drug Discov
.
2017 Dec;16(12):819.
doi: 10.1038/nrd.2017.169.
Epub 2017 Oct 23.
Authors
Alpha Tom Kodamullil
1
,
Firas Zekri
2
,
Meemansa Sood
1
,
Bastian Hengerer
3
,
Luc Canard
4
,
Duncan McHale
5
,
Martin Hofmann-Apitius
1
Affiliations
1
Fraunhofer Institute for Algorithms and Scientific Computing, Sankt Augustin 53754, Germany.
2
University of Sfax, B.P. 1088, 3018, Tunisia.
3
Boehringer Ingelheim Pharma, 88397 Biberach an der Riss, Germany.
4
Sanofi, Chilly-Mazarin Cedex 91385, France.
5
UCB Pharma, Belgium. Present address: Weatherden Ltd, Canterbury, Kent CT3 1TB, UK.
PMID:
29056749
DOI:
10.1038/nrd.2017.169
No abstract available